Andrx Can't Beat AstraZeneca's Prilosec Patent Suit
A New York federal judge on Monday refused to kill AstraZeneca's suit seeking nearly $500 million over Andrx Pharmaceuticals Inc.'s manufacture of a generic version of its indigestion drug Prilosec, saying...To view the full article, register now.
Already a subscriber? Click here to view full article